NEW YORK (GenomeWeb News) – Investment firm Obrem Capital Management disclosed in a filing with the US Securities and Exchange Commission yesterday that it has purchased roughly 6.2 million shares of MDS’ common stock and now owns a 5.1 percent stake in the company.
 
Obrem and its affiliates have been accumulating shares in the Mississauga, Ontario-based firm since late February.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.